When access reviews and revocation are weak, users can retain access after their role changes or after a study closes. That creates compliance exposure, unnecessary data access, and audit gaps. The practical failure is not only security drift. It is also operational delay, because teams spend time reconstructing who should still have access instead of proving it from the outset.
Why This Matters for Security Teams
In clinical research, access reviews and revocation are not administrative afterthoughts. They are the control that determines whether former study staff, vendors, and analysis tools can still reach regulated datasets after a role change, site closure, or protocol amendment. When those controls drift, organisations lose confidence in who can see PHI, source data, and blinded trial assets, and audit readiness collapses.
This is a governance problem as much as a security one. NIST Cybersecurity Framework 2.0 treats access control and continuous governance as core outcomes, while NHIMG’s Ultimate Guide to NHIs shows how weak lifecycle discipline leaves identities and secrets active long after they should be retired. NHIMG reports that only 20% of organisations have formal offboarding and API key revocation processes, which is a strong signal that many environments still rely on manual memory instead of controlled deprovisioning.
In practice, many security teams discover the problem only after a study closeout, an inspection request, or an unexpected access log review exposes that old permissions were never removed.
How It Works in Practice
Clinical research programmes usually involve humans, service accounts, shared integrations, and data platforms, so revocation must cover more than employee badges. The practical failure starts when access reviews are treated as periodic attestations rather than a linked process that reflects study status, role status, and sponsor constraints. If a CRA, data manager, or external statistician moves projects, their access should be reassessed immediately, not at the next quarterly cycle.
Effective governance usually combines three mechanics: inventory, decisioning, and proof. First, teams need a current inventory of who and what can access each study system, including non-human identities and delegated tools. Second, review decisions should be tied to source-of-truth events such as termination, contract end, protocol closure, or site deactivation. Third, revocation must be verifiable through logs, tickets, or policy outputs so auditors can see when access was removed and by whom. The control logic should reflect the principles in OWASP Non-Human Identity Top 10, especially around lifecycle management, standing privilege, and secret hygiene.
NHIMG’s Regulatory and Audit Perspectives discussion is useful here because clinical research teams need not just removal, but evidence of removal. That means revocation workflows should reach IAM, PAM, data platforms, EDC systems, cloud consoles, and any API keys used for automated exports or statistical pipelines. Where possible, automated deprovisioning should trigger from HR, CTMS, or study governance events rather than from manual checklists. Teams should also align access reviews with NIST SP 800-53 Rev 5 Security and Privacy Controls to support least privilege, account management, and auditability.
These controls tend to break down when study ownership is split across sponsors, CROs, and site partners because no single team owns the full offboarding path.
Common Variations and Edge Cases
Tighter revocation often increases coordination overhead, requiring organisations to balance rapid study delivery against the administrative burden of proving every access change. That tradeoff becomes visible in multi-site trials, emergency protocol amendments, and shared analytics environments where access has to change quickly without disrupting data collection.
Some environments also create exceptions that are operationally valid but risky. For example, read-only access may be retained briefly for inspection support, archive retrieval, or adverse event review. Current guidance suggests these exceptions should be explicitly time-bound and approved, not left as informal “temporary” access that becomes permanent. Similarly, shared vendor accounts, batch-processing identities, and service tokens require separate review logic because a human attestation process does not prove whether an API key still exists or still works.
Clinical research teams should distinguish between account removal and effective revocation. An account can be disabled in one system while the underlying token, export job, or federated entitlement remains active elsewhere. NHIMG’s Lifecycle Processes for Managing NHIs is especially relevant for this gap, because the hardest failures are often hidden in integration paths, not in primary user directories. Where organisations need a broader baseline, the Top 10 NHI Issues page helps frame how lifecycle drift and stale access become operational risk, not just compliance noise.
The edge case that most often causes trouble is a study that closes on paper while downstream data pipelines, audit archives, and third-party support accounts remain active in the background.
Standards & Framework Alignment
This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.
OWASP Non-Human Identity Top 10 address the attack and risk surface, while NIST CSF 2.0, NIST SP 800-53 Rev 5 and NIST AI RMF set the governance and control requirements practitioners need to meet.
| Framework | Control / Reference | Relevance |
|---|---|---|
| OWASP Non-Human Identity Top 10 | NHI-01 | Lifecycle drift and stale access are core non-human identity risks in this question. |
| NIST CSF 2.0 | PR.AC-4 | Least privilege and access governance directly address overdue revocation and review gaps. |
| NIST SP 800-53 Rev 5 | AC-2 | Account management control covers creation, review, disabling, and removal of access. |
| NIST AI RMF | GOVERN | AI RMF governance helps establish accountability for access decisions and exceptions. |
Inventory study and service identities, then revoke access immediately when the study or role ends.
Related resources from NHI Mgmt Group
- What breaks when cloud access reviews only look at job titles or high-level roles?
- What breaks when healthcare access reviews do not include privileged users and service accounts?
- How should security teams run access reviews for non-human identities?
- When do NHI access reviews create more value than a one-time cleanup?
Deepen Your Knowledge
Reviewed and updated by the NHIMG editorial team on August 27, 2026.
NHI Mgmt Group — the #1 independent authority on Non-Human Identity, IAM, and Agentic AI security. nhimg.org
